Literature DB >> 15050327

Rationale for radiotherapy as a treatment modality in gastric mucosa-associated lymphoid tissue lymphoma.

Won Park1, Sei Kyung Chang, Woo Ick Yang, Young Hyeh Ko, Seung Jae Huh, Yong Chan Ahn, Chang-Ok Suh.   

Abstract

PURPOSE: To provide a rationale for the use of local radiotherapy (RT) for the treatment of low-grade mucosa-associated lymphoid tissue lymphoma of the stomach (MLS). In addition, the clinicopathologic characteristics were analyzed. METHODS AND MATERIALS: The data of 72 patients with MLS, who underwent radical surgery between 1991 and 2001, were retrospectively reviewed. The depth of invasion into the gastric wall and the pattern of lymph node spread according to pathologic grade were analyzed.
RESULTS: The patient age range was 24-77 years (median, 51 years). Of the 72 patients, 45 (62.5%) had low-grade and 27 (37.5%) had high-grade MLS; 44 (61%) had Stage I and 28 (39%) Stage II. The tumors were confined to the mucosa or submucosa in 43 patients (58.9%). Sixty-seven percent of low-grade tumors and 48% of high-grade tumors were confined to the mucosa and submucosa. Lymph node involvement was identified in 24.4% of the low-grade MLS patients and 63.0% of the high-grade MLS patients. In the low-grade group, lymph node involvement was limited to the perigastric lymph nodes in all cases except for one. One patient with tumor infiltration beyond the serosa had extensive lymph node involvement into the paraaortic and omental lymph nodes.
CONCLUSION: Local RT to the stomach and regional lymphatics can be applied preferably instead of gastrectomy in patients with low-grade MLS who are negative for Helicobacter pylori or are refractory to anti-H. pylori therapy. The timing of RT and the exclusion criteria for RT should be determined in the future.

Entities:  

Mesh:

Year:  2004        PMID: 15050327     DOI: 10.1016/j.ijrobp.2003.09.002

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  Radiotherapy for mucosa-associated lymphoid tissue (MALT) lymphoma of the esophagus: a case report with a diagnostic and therapeutic discussion.

Authors:  Kazushi Kishi; Hiroki Maeda; Yasushi Nakamura; Shintaro Shirai; Morio Sato
Journal:  Int J Clin Oncol       Date:  2011-06-10       Impact factor: 3.402

2.  Clinical outcomes of radiation therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Sang-Won Kim; Do Hoon Lim; Yong Chan Ahn; Won Seog Kim; Seok Jin Kim; Young Hyeh Ko; Kyoung-Mee Kim
Journal:  World J Gastroenterol       Date:  2013-09-28       Impact factor: 5.742

3.  Risk factors and patterns of lymph node involvement in primary gastric large B-cell lymphoma: implications for target definition.

Authors:  Ximei Zhang; Peiguo Wang; Lujun Zhao; Zhiyong Yuan; Ping Wang
Journal:  Onco Targets Ther       Date:  2016-07-29       Impact factor: 4.147

4.  Radiation therapy for gastric mucosa-associated lymphoid tissue lymphoma: dose-volumetric analysis and its clinical implications.

Authors:  Hyeon Woo Lim; Tae Hyun Kim; Il Ju Choi; Chan Gyoo Kim; Jong Yeul Lee; Soo Jeong Cho; Hyeon Seok Eom; Sung Ho Moon; Dae Yong Kim
Journal:  Radiat Oncol J       Date:  2016-09-28

Review 5.  The Evolution in the Management of Gastric Lymphoma.

Authors:  Dana Hashim; Mariya Apostolova; Simon Lavotskin; Evan Goldstein; Mitchell Chorost
Journal:  Gastroenterology Res       Date:  2009-09-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.